IDO1 can be constitutively expressed by tumor cells or by macrophages, MDSCs and DCs in the tumor or the lymph nodes (198, 199) but can also be induced by inflammatory cytokines, such as IFN-γ, potentially inducing resistance to immunotherapy (200). Here, IFNG is linked to neoplasm.